JW Lifescience Corporation (KRX:234080)
South Korea · Delayed Price · Currency is KRW 12,600
-310 (-2.40%)
Last updated: Apr 2, 2026, 2:33 PM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 199.91 billion as of April 1, 2026. Its market cap has increased by 23.07% in one year.
Market Cap
199.91B
Enterprise Value
239.99B
Revenue
257.83B
Ranking
n/a
PE Ratio
6.99
Stock Price
12,600.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 199.91B, a decrease of -41.21%. That is a compound annual growth rate of -5.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 193.56B | -2.72% |
| Dec 30, 2025 | 198.98B | 18.11% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samil Pharmaceutical Co.,Ltd | 228.22B |
| Chong Kun Dang Holdings | 227.32B |
| Samjin Pharmaceuticals | 225.54B |
| Daewon Pharmaceutical | 224.62B |
| Suheung | 211.25B |
| AptaBio Therapeutics | 203.68B |
| Jeil Pharmaceutical Co.,Ltd | 203.27B |
| Ilyang Pharmaceutical Co.,Ltd | 200.40B |